Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac vs Ketorolac with Cyclosporine for Dry Eye
NCT00520260Phase 4Completed
- Sponsor
- Florida Eye Microsurgical Institute
- Start
- Aug 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bromfenac sodium in dry eye disease (DED) (2 arms), sponsored by Florida Eye Microsurgical Institute. Primary endpoint: Ocular comfort at 6 weeks. Started Aug 2007; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00520260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520260.